(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






A Preview: Datadog, Akamai, Lyft, and Clover Health Earnings Due

  • August 06th, 2023
  • 249 views

On Tuesday, August 8, a lineup of companies is gearing up to unveil their financial performance, offering insights into their recent activities and market trends, including:

Datadog, Inc. (Nasdaq: DDOG), a leader in monitoring and analytics solutions, is set to report its second-quarter fiscal-year 2023 financial results before the opening of the U.S. financial markets.

Analysts project an EPS of $0.28 on revenue totaling $500.6 million.

$DDOG closed at $107.53 on Friday, reflecting a gain of $0.43 (+0.40%).

Akamai Technologies, Inc. (Nasdaq: AKAM), a key player in content delivery and cloud services, will be releasing its second quarter 2023 earnings results following the close of the market.

The consensus EPS estimate stands at $1.41 with revenue amounting to $929.69 million.

On Friday, $AKAM closed at $92.63, down $0.11 (-0.12%).

Lyft, Inc. (Nasdaq: LYFT), a major player in the ride-hailing industry, is scheduled to release financial results for the second fiscal quarter of 2023 after the market concludes.

Analysts are forecasting a loss of $0.01 per share on revenue reaching $1.02 billion.

$LYFT closed at $10.85 on Friday, marking a decrease of $0.66 (-5.73%).

Clover Health Investments, Corp. (Nasdaq: CLOV), a healthcare technology company, will report its second quarter 2023 financial results after the market close.

The consensus estimate points to a loss of $0.15 per share with revenue projected to reach $490.82 million.

On Friday, $CLOV closed at $1.32, down $0.03 (-2.22%)

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments